CELOX technology created and developed by Medtrade Products Ltd, is a world-leading, UK-based medical device company, since 1999. Using patented and evidence-based technologies we tackle the global biofilm challenge, support the healing of wounds, and stop bleeding through continual product innovation. In 2006, we achieved a technological breakthrough with the launch of our CELOX haemostats. The technology embedded in these products was found to save lives on the battlefield by halting life-threatening bleeding. Our highly skilled experts have a wealth of knowledge in materials science, regulatory matters, quality requirements and manufacturing processes, and uses this to bring to market ground-breaking innovations that rapidly, safely, and effectively treat life-threatening bleeding in pre-hospital emergency situations.